Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shattuck Labs ( (STTK) ) has issued an update.
On August 26, 2025, Shattuck Labs announced the closing of a private placement of up to $103 million, led by OrbiMed, which is expected to fund operations into 2029 and advance their lead program, SL-325, through multiple clinical milestones. The company also appointed Dr. Daniel Baker and Dr. Mona Ashiya to its Board of Directors, marking a strategic repositioning towards an immunology and inflammation-focused organization. These developments are significant as they aim to enhance Shattuck’s industry positioning and potentially improve outcomes for patients with immune-mediated diseases.
The most recent analyst rating on (STTK) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Shattuck Labs stock, see the STTK Stock Forecast page.
Spark’s Take on STTK Stock
According to Spark, TipRanks’ AI Analyst, STTK is a Neutral.
Shattuck Labs’ overall stock score is primarily impacted by its challenging financial performance and bearish technical indicators. However, the recent $103 million private placement funding provides a positive outlook, potentially stabilizing the company’s financial position and supporting future growth. The stock’s valuation remains a concern due to negative earnings and lack of dividend yield.
To see Spark’s full report on STTK stock, click here.
More about Shattuck Labs
Shattuck Labs, Inc. is a biotechnology company focused on developing novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for treating inflammatory and immune-mediated diseases. The company specializes in the development of potential treatments for autoimmune and inflammatory diseases, with its lead program, SL-325, being a potential first-in-class DR3 antagonist antibody designed to block the DR3/TL1A pathway. Shattuck Labs operates from Austin, Texas, and Durham, North Carolina.
Average Trading Volume: 1,884,368
Technical Sentiment Signal: Sell
Current Market Cap: $47.6M
Learn more about STTK stock on TipRanks’ Stock Analysis page.